Amino Collective — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
Kernal Bio is a synthetic biology company developing selective mRNA drugs to treat serious illnesses, with a focus on cancer therapeutics and improving patient outcomes.
AI & Machine LearningBiotechHealthtechMedical DevicesBoston, US
Yusuf Erkul(Founder)inJeff Ozdemir(Founder)inBurak Yilmaz(Founder)inCatherine Moroski(Executive Officer, Director)inOguzhan Yilmas(Director)Burak YILMAZ(Founder)in
Co-investorsAsymmetry VenturesCivilization Ventures Management, LlcFoundersX VenturesGaingelsHOF CapitalHummingbird Ventures+13 more
Nostos Genomics develops genetic testing interpretation tools to improve the accuracy, speed, and accessibility of variant analysis for patients with rare and genetic diseases.
AI & Machine LearningBiotechDigital HealthHealthtechBerlin, DE
David Gorgan(Co-founder)inRocio Acuna Hidalgo(Co-founder)in
Co-investors42CAPAcequia Capital (AceCap)Entrepreneur FirstFaberFrontline VenturesMK Venture Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.






__Twitter.png)



